223 related articles for article (PubMed ID: 38034507)
1. Combining samidorphan with olanzapine to mitigate weight gain as a side effect in schizophrenia treatment.
Grywińska WB; Głowacka A
Postep Psychiatr Neurol; 2023 Sep; 32(3):128-137. PubMed ID: 38034507
[TBL] [Abstract][Full Text] [Related]
2. Mitigation of Olanzapine-Induced Weight Gain With Samidorphan, an Opioid Antagonist: A Randomized Double-Blind Phase 2 Study in Patients With Schizophrenia.
Martin WF; Correll CU; Weiden PJ; Jiang Y; Pathak S; DiPetrillo L; Silverman BL; Ehrich EW
Am J Psychiatry; 2019 Jun; 176(6):457-467. PubMed ID: 30845818
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine/Samidorphan: A New Combination Treatment for Schizophrenia and Bipolar I Disorder Intended to Reduce Weight Gain.
Corrao MM; Nelson LA
CNS Drugs; 2022 Jun; 36(6):605-616. PubMed ID: 35644903
[TBL] [Abstract][Full Text] [Related]
4. Effects of Olanzapine Combined With Samidorphan on Weight Gain in Schizophrenia: A 24-Week Phase 3 Study.
Correll CU; Newcomer JW; Silverman B; DiPetrillo L; Graham C; Jiang Y; Du Y; Simmons A; Hopkinson C; McDonnell D; Kahn RS
Am J Psychiatry; 2020 Dec; 177(12):1168-1178. PubMed ID: 32791894
[TBL] [Abstract][Full Text] [Related]
5. Samidorphan/olanzapine combination therapy for schizophrenia: Efficacy, tolerance and adverse outcomes of regimen, evidence-based review of clinical trials.
Rehan ST; Siddiqui AH; Khan Z; Imran L; Syed AA; Tahir MJ; Jassani Z; Singh M; Asghar MS; Ahmed A
Ann Med Surg (Lond); 2022 Jul; 79():104115. PubMed ID: 35860157
[TBL] [Abstract][Full Text] [Related]
6. Samidorphan mitigates olanzapine-induced weight gain and metabolic dysfunction in rats and non-human primates.
Cunningham JI; Eyerman DJ; Todtenkopf MS; Dean RL; Deaver DR; Sanchez C; Namchuk M
J Psychopharmacol; 2019 Oct; 33(10):1303-1316. PubMed ID: 31294646
[TBL] [Abstract][Full Text] [Related]
7. Samidorphan for the treatment of weight gain associated with olanzapine in patients with schizophrenia and bipolar disorder.
Gao J; Li J; Lu X; Yang J
Expert Rev Clin Pharmacol; 2022 Sep; 15(9):1011-1016. PubMed ID: 36016507
[TBL] [Abstract][Full Text] [Related]
8. Olanzapine/Samidorphan: A New Option for the Treatment of Adults With Schizophrenia or Bipolar I Disorder.
Pham H; Warlick H; Bermudez R; Nguyen Q; Rey JA
J Pharm Technol; 2022 Oct; 38(5):304-313. PubMed ID: 36046346
[TBL] [Abstract][Full Text] [Related]
9. Combination of olanzapine and samidorphan has no clinically relevant effects on ECG parameters, including the QTc interval: Results from a phase 1 QT/QTc study.
Sun L; Yagoda S; Xue H; Brown R; Nangia N; McDonnell D; Rege B; von Moltke L; Darpo B
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jun; 100():109881. PubMed ID: 32004636
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and Short-term Safety of ALKS 3831, a Fixed-dose Combination of Olanzapine and Samidorphan, in Adult Subjects with Schizophrenia.
Sun L; McDonnell D; von Moltke L
Clin Ther; 2018 Nov; 40(11):1845-1854.e2. PubMed ID: 30348514
[TBL] [Abstract][Full Text] [Related]
11. Olanzapine/Samidorphan: First Approval.
Paik J
Drugs; 2021 Aug; 81(12):1431-1436. PubMed ID: 34304374
[TBL] [Abstract][Full Text] [Related]
12. Olanzapine/Samidorphan: New Drug Approved for Treating Bipolar I Disorder and Schizophrenia.
Monahan C; McCoy L; Powell J; Gums JG
Ann Pharmacother; 2022 Sep; 56(9):1049-1057. PubMed ID: 35040357
[TBL] [Abstract][Full Text] [Related]
13. Olanzapine-samidorphan combination tablets for the treatment of schizophrenia and bipolar I disorder - what is it, and will it be used?
Faden J; Serdenes R; Citrome L
Expert Rev Neurother; 2022 May; 22(5):365-376. PubMed ID: 35354374
[TBL] [Abstract][Full Text] [Related]
14. Combination Olanzapine and Samidorphan for the Management of Schizophrenia and Bipolar 1 Disorder in Adults: A Narrative Review.
Haddad HW; Boardman E; Williams B; Mouhaffel R; Kaye AM; Kaye AD
Health Psychol Res; 2022; 10(3):34224. PubMed ID: 35774916
[TBL] [Abstract][Full Text] [Related]
15. Population Pharmacokinetics of Olanzapine and Samidorphan When Administered in Combination in Healthy Subjects and Patients With Schizophrenia.
Sun L; Mills R; Sadler BM; Rege B
J Clin Pharmacol; 2021 Nov; 61(11):1430-1441. PubMed ID: 34018607
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis comparing short-term weight and cardiometabolic changes between olanzapine/samidorphan and olanzapine.
Srisurapanont M; Suttajit S; Likhitsathian S; Maneeton B; Maneeton N
Sci Rep; 2021 Apr; 11(1):7583. PubMed ID: 33828206
[TBL] [Abstract][Full Text] [Related]
17. A Phase I Open-Label Study to Evaluate the Effects of Rifampin on the Pharmacokinetics of Olanzapine and Samidorphan Administered in Combination in Healthy Human Subjects.
Sun L; McDonnell D; Yu M; Kumar V; von Moltke L
Clin Drug Investig; 2019 May; 39(5):477-484. PubMed ID: 30888624
[TBL] [Abstract][Full Text] [Related]
18. In vivo Characterization of the Opioid Receptor-Binding Profiles of Samidorphan and Naltrexone in Rats: Comparisons at Clinically Relevant Concentrations.
Tan LA; Gajipara N; Sun L; Bacolod M; Zhou Y; Namchuk M; Cunningham JI
Neuropsychiatr Dis Treat; 2022; 18():2497-2506. PubMed ID: 36345421
[TBL] [Abstract][Full Text] [Related]
19. Olanzapine and samidorphan combination treatment: A systematic review.
Jawad MY; Alnefeesi Y; Lui LMW; Ceban F; Chen-Li DCJ; Teopiz K; Jaberi S; Gillissie ES; Vincenzo JDD; Rosenblat JD; McIntyre RS
J Affect Disord; 2022 Mar; 301():99-106. PubMed ID: 35007644
[TBL] [Abstract][Full Text] [Related]
20. An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder.
Citrome L; Graham C; Simmons A; Jiang Y; Todtenkopf MS; Silverman B; DiPetrillo L; Cummings H; Sun L; McDonnell D
Neuropsychiatr Dis Treat; 2021; 17():2885-2904. PubMed ID: 34526769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
